Hypertension-related morbidity and mortality in the Southeastern United States

American Journal of the Medical Sciences

Volumn 313, Issue 4, 1997, Pages 195-209

  Hall, W Dallas ^a,j   Ferrario, Carlos M ^b   Moore, Michael A ^c   Hall, John E ^d   Flack, John M ^b   Cooper, Warren ^e   Simmons, J Dale ^f   Egan, Brent M ^g   Lackland, Daniel T ^g   Perry Jr , Mitchell ^h   Roccella, Edward J ⁱ  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

^c Danville Urological Clinic   (United States)

^d UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^e Astra Merck   (United States)

^f N Carolina Dept Environ H   (United States)

^g MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^h WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^j NONE   (United States)

more..

Author keywords

Cardiovascular disease; Hypertension; Regional; Southeast; Stroke

Indexed keywords

ARTICLE; CONGESTIVE HEART FAILURE; DISEASE ASSOCIATION; FEMALE; HUMAN; HYPERTENSION; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; PREVALENCE; STROKE; UNITED STATES;

EID: 17944386089     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000441-199704000-00002     Document Type: Article

References (189)

1. Roccella EJ, Lenfant C. Regional and racial differences among stroke victims in the United States. Clin Cardiol, 1989; 12(suppl IV): IV-18-22.
2. U.S. Bureau of the Census. Statistical Abstract of the United States: 1993, 113th edition. Washington DC; 1993.
3. Lipkind KL. National Hospital Ambulatory Medical Care Survey: 1994 Outpatient Department Summary. Advance data, Vital Health Stat; No. 276. Hyattsville, MD: National Center for Health Statistics; June 11, 1996:1-12. DHHS publication (PHS) 96-1250.
4. Schappert SM. National Ambulatory Medical Care Survey: 1994 Summary. Advance Data, Vital Health Stat; No 273. Hyattsville, MD: National Center for Health Statistics; 1996:1-20. DHHS publication (PHS) 96-1250.
5. Burt VL, Whelton P, Roccella EJ, Brown C, Cutler JA, Higgins M, et al. Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988-1991. Hypertension. 1995;25:305-13.
6. Burt V. Preliminary data from the Third National Health and Nutrition Examination Survey (NHANES III), 1988-91. Hyattsville, MD: Centers for Disease Control and Prevention, National Center for Health Statistics; June 1996.
7. Lackland DT, Egan BM, Hudson MB, Jones PJ. Dramatic effects of nativity on strokebelt mortality in blacks (abstract). Am J Hypertens. 1996;9(4, Part 2):18A.
8. Fang J, Madhaven S, Alderman MH. The association between birthplace and mortality from cardiovascular causes among black and white residents of New York City. N Engl J Med. 1996;335:1545-51.
9. Lee TH, Alderman MH. Malignant hypertension. Declining mortality rate in New York City, 1958 to 1974. New York State Journal of Medicine. 1978;78:1389-91.
10. Webster J, Petrie JC, Jeffers TA, Lovell HG. Accelerated hypertension - patterns of mortality and clinical factors affecting outcome in treated patients. QJM. 1993;86:485-93.
11. Calhoun DA, Oparil S. Hypertensive crisis since FDR -a partial victory. N Engl J Med. 1995;332:1029-30.
12. Battey LL, Felner JM, Hall WD. Clinical manifestations of 104 patients with diastolic blood pressure ≥ 140 mm Hg. Emory University Journal of Medicine. 1988;2:102-5.
13. Davis BA, Crook JE, Vestal RE, Oates JA. Prevalence of renovascular hypertension in patients with grade III or IV hypertensive retinopathy. N Engl J Med. 1979;301:1273-6.
14. Wilber JA, Barrow JG. Hypertension - a community problem. Am J Med. 1972;52:653-63.
15. Winickoff RN, Murphy PK. The persistent problem of poor blood pressure control. Arch Intern Med. 1987;147:1393-6.
16. Roccella EJ, Horan MJ. The National High Blood Pressure Education Program: Measuring progress and assessing its impact. Health Psychol. 1988;7(suppl):297-303.
17. Goldman L, Cook EF. The decline in ischemic heart disease mortality rates: An analysis of the comparative effects of medical interventions and changes in lifestyle. Ann Intern Med. 1984;101:825-36.
18. Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. The fifth report of the Joint National Committee on the Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med. 1993;153:154-83.
19. Drizd T, Dannenberg AL, Engel A. Blood pressure levels in persons 18-74 years of age in 1976-1980, and trends in blood pressure from 1960-1980 in the United States. National Center for Health Statistics, Vital Health Stat, Series 11, No 234. Washington, DC: Public Health Service; 1986:10-18. US Government Printing Office DHHS publication (PHS) 86-1684.
20. Public Health Service. Healthy People 2000 review, 1993. Washington, DC: 1993. Government Printing Office DHHS publication PHS 94-1232-1.
21. NHLBI Data Fact Sheet. The stroke belt: Stroke mortality by race and sex. Department of Health and Human Services, Public Health Service, National Institutes of Health, October 1989.
22. National Center for Health Statistics. Health, United States, 1990. Hyattsville, MD: National Center for Health Statistics; 1991:18-23,38,42. DHHS publication (PHS) 91-1232.
23. Miller JP, Perry HM Jr, Rossiter JE, Baty JD, Carmody SE, Sambhi MP. Regional difference in mortality during 15-year follow-up of 11,936 hypertensive veterans. Hypertension. 1994;23:431-8.
24. Heyman A, Tyroler HA, Cassel JC, O'Fallon WM, Davis L, Mulbaier L. Geographic differences in mortality from stroke in North Carolina. Stroke. 1976;7:41-5.
25. Gross CR, Kase CS, Mohr JP, Cunningham SC, Baker WE. Stroke in south Alabama: Incidence and diagnostic features - a population-based study. Stroke. 1984;15:249-55.
26. Kurtzke JF, Beebe GW, Norman Jr JE. Epidemiology of multiple sclerosis in US veterans. Neurology. 1985;35:672-8.
27. Blythe WB, Maddux FW. Hypertension as a causative diagnosis of patients entering end-stage renal disease programs in the United States from 1980 to 1986. Am J Kidney Dis. 1991;18:33-7.
28. U.S. Renal Data System. USRDS 1995 Annual Data Report. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Disease; 1995:21,29,32,B20,B41. NIH publication 95-3176.
29. Health Care Financing Research Report. End Stage Renal Disease. Research Triangle Park, Raleigh, NC: Department of Health and Human Services; 1984. HCFA publication 03221.
30. Rosansky SJ, Huntsberger TL, Jackson K, Eggers P. Comparative incidence rates of end-stage renal disease treatment by state. Am J Nephrol. 1990;10:198-204.
31. Qualheim RE, Rostand SG, Kirk KA, Rutsky EA, Luke RG. Changing patterns of end-stage renal disease due to hypertension. Am J Kidney Dis. 1991;18:336-43.
32. Foxman B, Moulton LH, Wolfe RA, Guire KE, Port FK, Hawthorne VM. Geographic variation in the incidence of treated end-stage renal disease. J Am Soc Nephrol. 1991;2:1144-52.
33. Perry HM, Miller JP, Fornoff JR, Baty JD, Sambhi MP, Rutan G, et al. Early predictors of 15-year end-stage renal disease in hypertensive patients. Hypertension. 1995;25:587-94.
34. Moore MA. End-stage kidney disease: A southern epidemic. South Med J. 1994;87:1013-7.
35. Whelton PK, Klag MJ. Hypertension as a risk factor for renal disease. Review of clinical and epidemiological evidence. Hypertension. 1989;13(suppl 1):I19-27.
36. Flack JM, Neaton JD, Daniels B, Esunge P. Ethnicity and renal disease: Lessons from the Multiple Risk Factor Intervention Trial and the Treatment of Mild Hypertension Study. Am J Kidney Dis. 1993;21(4, suppl 1):31-40.
37. Klag MJ, Whelton PK, Randall BL, Neaton JD, Brancati FL, Ford CE, et al. Blood pressure and end-stage renal disease in men. N Engl J Med. 1996;334:13-8.
38. Centers for Disease Control and Prevention. Chronic Disease in Minority Populations. Atlanta: Centers for Disease Control and Prevention; 1992:2-5.
39. Rostand SG. US minority groups and end-stage renal disease: A disproportionate share. Am J Kidney Dis. 1992;19:411-3.
40. Young EW, Mauger EA, Jiang K-H, Port FK, Wolfe RA. Socioeconomic states and end-stage renal disease in the United States. Kidney Int. 1994;45:907-11.
41. Perneger TV, Whelton PK, Klag MJ, Rossiter KA. Diagnosis of hypertensive end-stage renal disease: Effect of patient's race. Am J Epidemiol. 1995;141:10-15.
42. Aubert RE, Blount SB. Variability of hypertension-related mortality in the United States, 1968-1986. J Human Hypertens. 1990;4:97-99.
43. National Center for Health Statistics. Annual summary of births, marriages, divorces and deaths. United States, 1994. Monthly Vital Statistics Report. 1995;43:13.
44. National Heart, Lung and Blood Institute. Morbidity and mortality; 1996 chartbook on cardiovascular, lung, and blood diseases. DHHS, PHS, NIH, May 1996.
45. National Center for Health Statistics, Births, marriages, divorces, and deaths for January 1996. Monthly vital statistics report, Vol 45, No 1. Hyattsville, MD: Public Health Service: 1996:13.
46. Keil JE, Sutherland SE, Hames CG, Lackland DT, Gazes PC, Knapp RG, et al. Coronary disease mortality and risk factors in black and white men. Results from the combined Charleston, SC and Evans County, Georgia, heart studies. Arch Intern Med. 1995;155:1521-7.
47. Siegel PZ, Frazier EL, Mariolis P, Brackbill RM, Smith C. Behavioral risk factor surveillance, 1991: Monitoring progress toward the nation's year 2000 health objectives. MMWR. 1993;42(SS-4):1-17.
48. Levy D, Larson MG, Vasan RS, Kannel WB, Ho KKL. The progression from hypertension to congestive heart failure. JAMA. 1996;275:1557-62.
49. Yusuf S, Thom T, Probstfleld J. The public health and clinical implication of the national increase in congestive heart failure. In: Morganroth J, Moore NE; eds. Congestive Heart Failure. Dordrecht, Netherlands: Martinus Nijhoff Publishers: 1987:1-7.
50. Schocken DD, Arrieta MI, Leaverton PE. Prevalence and mortality rate of congestive heart failure in the United States. J Am Coll Cardiol. 1992;20:301-6.
51. National Center for Health Statistics. National Hospital Discharge Survey. Hyattsville, MD: Vital Health Stat, Series 13, 1970-1995.
52. Ghali JK, Cooper R, Ford E. Trends in hospitalizatioti rates for heart failure in the U.S., 1973-1986: Evidence for increasing prevalence. Arch Intern Med. 1990;150:769-73.
53. Yusuf S, Thom T, Abbott RD, Changes in hypertension treatment and in congestive; heart failure mortality in the United States. Hypertension. 1989;13(suppl 1): I74-79.
54. Centers for Disease Control. Mortality from congestive heart failure - United States, 1980-1990. MMWR. 1994:43(5):77-81.
55. Kannel WB, Ho K, Thom T, Changing epidemiological features of cardiac failure. Br Heart J. 1994;72(suppl):S3-9.
56. Perry HM Jr, Romeis JC, Sambhi MP, Smith MM, Virgo KS, Gillespie KN, Carmody S. Increased all-cause mortality among hypertensive veterans from the "Stroke Belt" region of the southeast United States. J Hypertens. 1994;12:315-21.
57. Lackland DT, Keil JF, Gazes PC, Hames, CG, Tyroler HA, Outcomes of black and white hypertensive individuals after 30 years of follow-up. Clin Exp Hypertens. 1995;17:1091-1105.
58. Raison J, Achimastos A, Bouthier J, London G, Safar M. Intravascular volume, extracellular fluid volume and total body water in obese and nonobese hypertensive patients, Am J Cardiol. 1983;51:165-70.
59. Kumanyika SK. Weight reduction and sodium restriction in the management of hypertension. Clin Geriatr Med. 1989;5:769-89.
60. Eliahou HE, Shechter P, Blau A. Hypertension and obesity. In: Bjorntorp P, Brodoff BN; eds. Obesity. Philadelphia: J.B. Lippincott Co.; 1992;532-9.
61. Hall JE, Brands MW, Hildebrandt DA, Mizelle HL. Obesity-associated hypertension. Hyperinsulinemia and renal mechanisms. Hypertension. 1992;19(suppl 1):I45-55.
62. Kumanyika SK. Diet and nutrition as influences on the morbidity/mortality gap. Ann Epidemiol. 1993;3;154-8.
63. Kumanyika SE, Landis JR, Matthews YL, Weaver SL, Harlan LC, Harlan WR. Secular trends in blood pressure among adults blacks and whites aged 18-34 years in two body mass index strata, United States, 1960-1980. Am J Epidemiol. 1994;139:141-54.
64. Hall JE Renal and cardiovascular mechanisms of hypertension in obesity. Hypertension. 1994;23:381-94.
65. Tyroler HA, Hayden S, Hames CG. Weight and hypertension: Evans County studies of blacks and whites. In: Oglesby P; ed. Epidemiology and Control of Hypertension. New York: Stratton Intercontinental; 1975;177-201.
66. Havlik RJ, Hubert HB, Fabsitz RR, Feinleib M. Weight and hypertension. Ann Intern Med. 1983:98:855-9.
67. Haffner SM, Mitchell BD, Valdez RA, Hazuda HP, Morales PA, Stern MP. Eight-year incidence of hypertension in Mexican-Americans and non-Hispanic whites. The San Antonio Heart Study. Am J Hypertens. 1992;5:147-53.
68. Jones DW, Kim JS, Andrew ME, Kim SJ, Hong YP. Body mass index and blood pressures in Korean men and women: The Korean National Blood Pressure Survey. J Hypertens. 1994;12:1433-7.
69. Kannel WB, Brand M, Skinner J, Dawber T, McNamara P Relation of adiposity to blood pressure and development of hypertension: The Framingham Study. Ann Intern Med. 1967;67:48-59.
70. Gordon T, Kannel WB. Obesity and cardiovascular disease: The Framingham study. Clin Endocrinol Metab. 1976;5:367-5.
71. Stamler R, Stamler J, Riedlingcr WF, Algera G, Rob erts RH. Weight and blood pressure: Findings in hypertension screening of 1 million Americans. JAMA. 1978;240:1607-10.
72. Alexander J, Dustan HP, Sims EAH, Tarazi R. Report of the Hypertension Task Force. Vol 9, Washington DC: US Government Printing Office: 1979:61-77. US Dept of Health, Education, and Welfare publication 70-1631 (NIH).
73. Rocchini AP, Moorehead CP, Wentz E, DeRemer S. Obesity-induced hypertension in the dog. Hypertension 1987;9(suppl 3):III-64-68.
74. Hall JE, Brands MW, Dixon WN, Smith MJ Jr. Obesity-induced hypertension: Renal function and systemic hemodynamics. Hypertension. 1993;22:292-9.
75. Fletcher AP. The effect of weight reduction upon the blood pressure of obese hypertensive women. QJM. 1954;23:331-45.
76. Salzano JV, Gunning RV, Mastopaulo TN, Tuttle WW. Effect of weight loss on blood pressure. J Am Diet Assoc. 1958;34:1309-12.
77. Reisen E, Abel R, Modan M, Silverberg DS, Eliahou HE, Modan B. Effect of weight loss without salt restriction on the reduction of blood pressure in overweight hypertensive patients. N Engl J Mod. 1978;298:1-6.
78. Sowers JR, Nyby M, Stern N, Beck F, Baron S, Catania R, Vlachis N. Blood pressure and hormone changes associated with weight reduction in the obese. Hypertension. 1982;4:686-91.
79. Rocchini AP, Key J, Bordie D, Chico R, Moorhead C, Katch V, et al. The effect of weight loss on the sensitivity of blood pressure to sodium in obese adolescents. N Engl J Med. 1989;321:580-5.
80. Oberman A, Wassertheil-Smoller S, Langford HG, Blaufox MD, Davis BR, Blaszkowski T, et al. Pharmacologic and nutritional treatment of mild hypertension: Changes in cardiovascular risk status. Ann Intern Med. 1990;112:89-95.
81. Stamler J. Epidemic obesity in the United States, Arch Intern Med. 1993;153:1040-4.
82. Kuczmarski RJ, Flegal KM, Campbell SM, Johnson CL. Increasing prevalence of overweight among US adults: The National Health and Nutrition Examination Surveys, 1960 to 1991. JAMA. 1994;272:205-11.
83. Kumanyika S. Obesity in black women. Epidemiol Rev. 1987;9:31-50.
84. Jones DW. Body weight and blood pressure. Effects of weight reduction on hypertension. Am J Hypertens. 1996;9(suppl):50S-4S.
85. Lackland DT, Orchard TJ, Keil JE, Saunders Jr DE, Wheeler FC, Adams-Campbell LL, et al. Are race differences in the prevalence of hypertension explained by body mass and fat distribution? A survey in a biracial population. Int J Epidemiol. 1992;21:236-45.
86. Giles WH, Croft JB, Keenan NL, Lane MJ, Wheeler FC. The validity of self-reported hypertension and correlates of hypertension awareness among blacks and whites within the stroke belt. Am J Prev Med. 1995;11:163-9.
87. Blair SN, Goodyear NN, Gibbons LW, Cooper KH. Physical fitness and incidence of hypertension in healthy normotensive men and women. JAMA. 1984;252:487-90.
88. NIH Concensus Development Panel on Physical Activity and Cardiovascular Health, Physical activity and cardiovascular health. JAMA. 1996;276:241-6.
89. Arroll B, Beaglehole RB. Does physical activity lower blood pressure. A critical review of the clinical trials. J Clin Epidemiol. 1992;45:439-47.
90. Kelley G, McClellan P. Antihypertensive effects of aerobicexercise, A brief metaanalytic review of randomized clinical trials. Am J Hypertens. 1994;7:115-9.
91. Arakawa K. Antihypertensive mechanism of exercise. J Hypertens. 1993;11:223-9.
92. Grassi G, Seravalle G, Calhoun DA, Mancia G. Physical training and baroreceptor control of sympathetic nerve activity in humans. Hypertension. 1994;23:294-301.
93. US Public Health Service. Healthy People 2000. National Health Promotion and Disease Prevention Objectives. Washington DC: 1991:55. DHHS publication (PHS) 91-50213.
94. US Department of Health and Human Services. Healthy People 2000 Review, 1995-96. Hyattsville, MD: 1996:31-3. DHHS publication (PHS) 96-1256.
95. Grim CE, Luft FC, Miller JZ, Luft FC, Christian JC, Weinberger MH. Racial differences in blood pressure in Evans County, Georgia: Relationship to sodium and potassium intake and plasma renin activity. J Chronic Dis. 1980;33:87-94.
96. Dai WS, Kuller LH, Miller G. Arterial blood pressure and urinary electrolytes. J Chronic Dis. 1984;37:75-84.
97. Veterans Administration Cooperative Study Group on Antihypertensive Agents. Urinary and serum electrolytes in untreated black and white hypertensives. J Chronic Dis. 1987;40:839-47.
98. Dietary Guidelines Advisory Committee. Report of the Dietary Guidelines Advisory Committee on the Dietary Guidelines for the Americans. Washington DC: US Dept Agriculture, DHHS; 1995.
99. National Center for Health Statistics. Carroll, MD, Abraham S, Dresser CM. Dietary intake source data: United States, 1976-80. Vital Health Stat [11] No 231. Washington, DC: Public Health Service, US Government Printing Office; March 1983:1-483. DHHS publication (PHS) 83-1681.
100. Popkin BM, Siega-Riz AM, Haines PS. A comparison of dietary trends among racial and socioeconomic groups in the United States. N Engl J Med. 1996;335:716-20.
101. Muntzel M, Drueke T. A comprehensive review of the salt and blood pressure relationship. Am J Hypertens. 1992;5(suppl):1S-42S.
102. Elliott P. Nutritional factors in blood pressure. J Hum Hypertens. 1994;8:595-601.
103. Luft FC, Weinberger MH, Review of salt restriction and the response to antihypertensive drugs. Hypertension. 1988;11(suppl 1):I229-32.
104. Williams GH, Hollenberg NK. Non-modulating hypertension. A subset of sodium sensitive hypertension. Hypertension. 1991;17(suppl 1):181-5.
105. Haddy FJ, Pamnani MB. Role of dietary salt in hypertension, J Am Coll Nutr. 1995;14:428-38.
106. Flack JM, Wiist WH. Epidemiology of hypertension and hypertensive target-organ damage in the United States. J Assoc Acad Minor Phys. 1991;2:143-50.
107. Luft FC, Weinberger MH, Grim CE. Sodium sensitivity and resistance in normotensive humans. Am J Med. 1082;72:725-36.
108. Campese VM. Salt sensitivity in hypertension. Renal and cardiovascular implications. Hypertension. 1994;23:531-50.
109. Bigazzi R, Bianchi S, Baldari D, Sgherri G, Baldari G, Campese VM. Microalbuminuria in salt-sensitive patients. A marker for renal and cardiovascular risk factors. Hypertension, 1994;23:195-9.
110. Bakris EL, Smith A. Effects of sodium intake on albumin excretion in patients with diabetic nephropathy treated with long-acting calcium antagonists. Ann Intern Med. 1996;125:201-4.
111. Perry IJ, Beevers DG. Salt intake and stroke: A possible direct effect. J Hum Hypertens. 1992;6:23-5.
112. Xie JX, Sasaki S, Joossens JV, Kesteloot H. The relationship between urinary cations obtained from the INTERSALT Study and cerebrovascular mortality. J Hum Hypertens. 1992;6:17-21.
113. Zemel P, Gualdoni S, Sowers JR. Racial differences in mineral intake in ambulatory normotensives and hypertensives. Am J Hypertens. 1988;1(suppI):146S-8S.
114. Langford HE. Dietary potassium and hypertension: Epidemiologic evidence. Ann Intern Med. 1983;98:770-2.
115. Langford HE. Can black/white differences in blood pressure and hypertensive mortality in the U.S. be explained by differences in potassium intake? In: Whelton PK, Whelton A, Walker WG; eds. Potassium in Cardiovascular and Renal Medicine. New York: Marcel Dekker Inc.; 1986:397-400.
116. Krishna GG, Miller E, Kapoor S. Increased blood pressure during potassium depletion in normotensive men. N Engl J Med. 1989;320:1177-82.
117. Tobian L, Lange J, Ulm K, Wold L, Iwai J. Potassium reduces cerebral hemorrhage and death rate in hypertensive rats, even when blood pressure is not lowered. Hypertension. 1985;7(suppl 1):I110- 4.
118. Tobian L. Evidence for a protective effect of potassium on renal function and cerebral arteries and arterioles. In: Whelton PK, Whelton A, Walker WG; eds. Potassium in Cardiovascular and Renal Medicine. New York: Marcel Dekker Inc.; 1986:391-6.
119. Tobian L. Hypothesis: Low dietary K may lead to renal failure in blacks with hypertension and severe intimal thickening. Am J Med Sci. 1988;295:384-8.
120. Khaw K-T, Barrett-Conner E. Dietary potassium and stroke-associated mortality. A 12-year prospective population study. N Engl J Med. 1987;316:235-40.
121. Kaplan NM, Carnegie A, Raskin P, Heller JA, Simmons M. Potassium supplementation in hypertensive patients with diuretic-induced hypokalemia. N Engl J Med. 1985;312:746-9.
122. Whelton PK, Appel LA, Seidler AJ, Thaker GK, Klag MJ. Potassium supplementation in the treatment and pre- vention of hypertension. J Hypertens. 1992;10(suppl 4):S108.
123. Shimakawa T, Sorlie P, Carpenter MA, Dennis B, Tell GS, Watson R, et al. for the ARIC Study Investigators: Dietary intake patterns and sociodemographic factors in the Atherosclerosis Risk in Communities Study. Prev Med. 1994;23:769-90.
124. Centers for Disease Control. Daily dietary fat and total food-energy intakes - Third National Health and Nutrition Examination Survey. Phase I, 1988-91. MMWR. 1904;43(7):116-7, 123-5.
125. Sacks FM. Dietary fats and blood pressure: A critical review of the evidence. Nutr Rev. 1989;47:291-300.
126. National High Blood Pressure Education Working Group. Working Group Report on primary prevention of hypertension. Arch Intern Med. 1993;153:186-208.
127. Snow LF. Folk medical beliefs and their implications for care of patients. Ann Intern Med. 1974;81:82-96.
128. Haynes RB, Mattson ME, Chobanian AV, Dunbar JM, Engebretson TO Jr, Garrity TF, et al. Management of patient compliance in the treatment of hypertension. Report of the NHLBI Working Group. Hypertension. 1982;4:415-23.
129. Tuomilehto J, Enlund H, Salonen JT, Nissinen A. Alcohol, patient compliance and blood pressure control in hypertensive patients. Scand J Soc Med. 1984;12:171-81.
130. Centers for Disease Control. Health beliefs, compliance - hypertension. MMWR. 1990;39:701-4.
131. Heurtin-Roberts S, Reisin E. The relation of culturally influenced lay models of hypertension to compliance with treatment. Am J Hypertens. 1992;5:787-92.
132. Shea S, Misra D, Ehrlich MH, Field L, Francis CK. Correlates of nonadherence to hypertension treatment in an inner-city minority population. Am J Public Health. 1992;82:1607-12.
133. Kravitz RL, Hays RD, Sherbourne CD, DiMatteo MR, Rogers WH, Ordway L, Greenfield S. Recall of recommendations and adherence to advice among patients with chronic medical conditions. Arch Intern Med. 1993;153:1869-78.
134. National Center for Chronic Disease Prevention and Health Promotion, CDC, Adults taking action to control their blood pressure - United States, 1990. MMWR. 1994;43(28):509-11, 517.
135. Klein LE. Compliance and blood pressure control. Hypertension. 1988;11(suppl 2):II-61-64.
136. Gallup Jr G, Cotugno HE. Preferences and practices of Americans and their physicians in antihypertensive therapy. Am J Med. 1986;81:20-4.
137. Haynes RB, Mattson ME, Engebretson Jr TO. Patient compliance to prescribed antihypertensive medication regimens: A report to the National Heart, Lung, and Blood Institute. Bethesda, MD: Government Printing Office; 1980. NIH publication 81-2102.
138. Bone LR, Levine DM, Parry RE, Morisky DE, Green LW. Update on the factors associated with high blood pressure compliance. Maryland State Medical Journal. 1984; 33:201-4.
139. Clark LT. Improving compliance and increasing control of hypertension: Needs of special hypertensive populations. Am Heart J. 1991;121:664-9.
140. Melnikow J, Kiefe C. Patient compliance and medical research: Issues in methodology. J Gen Intern Med. 1994;9:96-105.
141. Sanson-Fisher RW, Clover K. Compliance in the treatment of hypertension. A need for action. Am J Hypertens. 1995;8(suppl):82S-8S.
142. Stanton AL. Determinants of adherence to medical regimens by hypertensive patients. J Behav Med. 1987;10:377-94.
143. Greenberg RN. Overview of patient compliance with medication dosing: A literature review. Clin Ther. 1984;6:592-9.
144. Coons SJ, Sheahan SL, Martin SS, Hendricks J, Robbins CA, Johnson JA. Predictors of medication noncompliance in a sample of older adults. Clin Ther. 1994;16:436-40.
145. Eisen KA, Miller DK, Woodward RS, Spitznagel E, Przybeck TR, The effect of prescribed daily dose frequency on patient medication compliance. Arch Intern Med. 1990;150:1881-4.
146. Cramer JA, Mattson RH, Prevey ML, Scheyer RD, Ouellette VL. How often is medication taken as prescribed? A novel assessment technique. JAMA. 1989;261:3273-7.
147. Shulman N, Cutter G, Daugherty R, Sexton M, Pauk G, Taylor MJ, et al. Correlates of attendance and compliance in the Hypertension Detection and Follow-up Program. Control Clin Trials. 1982;3:13-27.
148. Yakovlevitch M, Black HR. Resistant hypertension in a tertiary care clinic. Arch Intern Med. 1991;151:1786-92.
149. McClellan WM, Hall WD, Brogan D, Miles C, Wilber JA. Continuity of care in hypertension: An important correlate of blood pressure control among aware hypertensives. Arch Intern Med. 1988;148:525-8.
150. Engelland AL, Alderman MH, Powell HB. Blood pressure control in private practice: A case report. Am J Public Health. 1979;69:25-9.
151. Ballard DJ, Strogatz DS, Wagner EH, Siscovick DS, James SA, Kleinbaum DG, et al. Hypertension control in a rural southern community: Medical care process and dropping out. Am J Prev Med. 1988;4:133-9.
152. Smith CM, Yawn BP. Factors associated with appointment keeping in a family practice residency clinic. J Fam Pract. 1994;38:25-9.
153. Caldwell JR, Theisen V, Kaunisto CA, et al. Psychosocial factors influence control of moderate and severe hypertension. Soc Sci Med. 1983;17:773-82.
154. Ballard DJ, Strogatz DS, Wagner EH, Siscovick DS, James SA, Kleinbaum DG, et al. The Edgewood County High Blood Pressure Control Program: The process of medical care and blood pressure control. Am J Prev Med. 1986;2:278-84.
155. Blane D, Smith GD, Bartley M. Social class differences in years of potential life lost: Size, trends, and principal causes. BMJ. 1990;301:429-32.
156. Weissman JS, Stern R, Fielding SL, Epstein AM, Delayed access to health care: Risk factors, reasons, and consequences. Ann Intern Med. 1991;114:325-31.
157. Sorel JE, Ragland DR, Syme SL, Davis WB. Educational status and blood pressure: The Second National Health and Nutrition Examination Survey, 1076-1980, and the Hispanic Health and Nutrition Examination Survey, 1982-1984. Am J Epidemiol. 1992;135:1339-48.
158. Moy E, Hogan C. Access to needed follow-up services. Variations among different Medicare populations. Arch Intern Med. 1993;153:1815-23.
159. Stockwell DH, Madhaven S, Cohen H, Gibson G, Alderman MH. The determinants of hypertension awareness, treatment, and control in an insured population. Am J Public Health. 1994;84:1768-74.
160. Himmelstein D. Care denied: US residents who are unable to obtain needed medical services. Am J Public Health, 1995;85:341-4.
161. Moy E, Bartman BA, Weir MR, Access to hypertensive care. Effects of income, insurance, and source of care. Arch Intern Med. 1995;155:1497-1502.
162. Lackland DT, McCurdy L, Bailey WP, Corley EH, Hudson MB, Zoller JS. Excess stroke mortality in rural populations: A need for access to primary care and alternate medical care services (abstract). Am J Hypertens. 1995;8:34A.
163. National Hospital Discharge Survey. Annual Summary, 1993. National Center for Health Statistics. Vital Health Stat. 1995;13(121).
164. National Ambulatory Medical Care Survey. 1989 Summary. National Center for Health Statistics. Vital Health Stat. 1992;13(110).
165. Moser M. Can the cost of care be contained and quality of care maintained in the management of hypertension? Arch Intern Mod. 1994;154:1665-72.
166. Kaplan NM. An examination of the retail cost of antihypertensive therapy. Am J Hypertens. 1994;7:675-6.
167. Brook RH, Ware JE Jr, Rogers WH, Keeler EB, Davies AR, Donald CA, et al. Does free care improve adults' health? Results from a randomized clinical trial, N Engl J Med. 1983;309:1426-34.
168. Harlan WR. Economic considerations that influence health policy and research. Hypertension. 1939;13(suppl 1):I58-63.
169. Edelson JT, Weinstein MC, Tosteson ANA, Williams L, Lee TH, Goldman L. Long-term cost-effectiveness of various initial monotherapies for mild to moderate hypertension. JAMA. 1990;263:407-13.
170. Shulman NB, Levinson RM, Dever GEA, Porter RS, Owen SL, Hall WD. Impact of cost problems on morbidity in a hypertensive population. Am J Prev Med. 1991;7:374-8.
171. Reif MC, Carter VL. The retail cost of therapy. Physician and patient as educated consumers. Am J Hypertens. 1994;7:571-5.
172. Hahn B, Flood AB. No insurance, public insurance, and private insurance: Do these options contribute to differences in general health? J Health Care Poor Underserved. 1995;6:41-59.
173. Moorman P, Hames C, Tyroler H. Socioeconomic status and morbidity and mortality in hypertensive blacks. In: Saunders E; ed. Cardiovascular Diseases in Blacks. Philadelphia: F.A. Davis Co.; 1991;179-94.
174. Kaplan NM. Hypertension in the population at large. In: Kaplan NM; ed. Clinical Hypertension, 6th ed. Baltimore: Williams & Wilkins; 1994;1-22.
175. Shulman NB, Martinez B, Brogan E, Can- AA, Miles CG. Financial cost as an obstacle to hypertension therapy. Am J Pub Health. 1986;76:1105-8.
176. Hypertension Detection and Follow-up Program Cooperation Group. Five-year findings of the Hypertension Detection and Follow-up Program III, Reduction in stroke incidence among persons with high blood pressure. JAMA. 1982;247:633-8.
177. Law CM, Barker DJP, Osmond C, Fall CHD, Simmonds SJ. Early growth and abdominal fatness in adult life. J Epidemiol Community Health. 1992;46:184-6.
178. Phipps K, Barker DJP, Hales CN, Fall CHD, Osmond C, Clark PMS. Fetal growth and impaired glucose tolerance in men and women. Diabetologia. 1993;36:225-8.
179. Phillips DIW, Barker DJP, Hales CN, Hirst S, Osmond C. Thinness at birth and insulin resistance in adult life. Diabetologia. 1994;37:150-4.
180. Yajnik CS, Fall CHD, Vaidya U, Pandit AN, Bavdekar A, Bhat DS, et al. Fetal growth and glucose and insulin metabolism in four-year-old Indian children. Diabet Med. 1995;12:330-6.
181. Barker DJP, Bull AR, Osmond C, Simmonds SJ. Fetal and placental size and risk of hypertension in adult life. BMJ. 1990;301:259-62.
182. Lopes AAS, Port FK. The low birthweight hypothesis as a plausible explanation for the black/white difference in hypertension, non-insulin-dependent diabetes, and end-stage renal disease. Am J Kidney Dis. 1995;25:350-6.
183. Lurbe E, Redon J, Alvarez V, Durazo R, Gomez A, Tacons J, et al. Relationship between birth weight and awake blood pressure in children and adolescents in absence of intrauterine growth retardation. Am J Hypertens. 1996;9:787-94.
184. Brenner BM, Garcia DL, Anderson S. Glomeruli and blood pressure. Less of one, more the other? Am J Hypertens. 1988;1:335-47.
185. Hinchliffe SA, Lynch MRJ, Sargent PH, Howard CV, Van Velzen D, The effect of intrauterine growth retardation on the development of renal nephrons. Br J Obstet Gynecol. 1992;99:296-301.
186. Brenner BM, Chertow GML. Congenital oligonephropathy and the etiology of adult hypertension and progressive renal injury. Am J Kidney Dis. 1994;23:171-5.
187. Fall CHD, Vijayakumar M, Barker DJP, Osmond C, Dubbleby S. Weight in infancy and prevalence of coronary heart disease in adult life. Lancet. 1995;310:17-9.
188. Fall CHD, Osmond C, Barker DJP, Clark PMS, Hales CN, Stirling Y, et al. Fetal and infant growth and cardiovascular risk factors in women. BMJ. 1995;310:428-32.
189. Barker DJP. Review: The fetal and infant origins of disease. Eur J Clin Invest. 1995:25:457-63.